• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR SARS-COV-2 TOTAL (COV2T); SARS-COV-2 IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR SARS-COV-2 TOTAL (COV2T); SARS-COV-2 IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/23/2020
Event Type  malfunction  
Manufacturer Narrative
Siemens has been on site and performed several total service calls on the instrument.The system was decontaminated.Siemens continues to investigate.The limitations section of the instructions for use states: "this assay should not be used to diagnose or exclude acute infection.Results are not intended to be used as the sole basis for patient management decisions.Test results should be interpreted in conjunction with clinical observations, patient history, epidemiological information, and other laboratory findings.A reactive test result does not exclude past or present infection by other coronaviruses, such as sars-cov-1, mers-cov, hku1, 229e, nl63, or oc43." a false positive/reactive result would not be used in isolation and would be correlated with clinical history.Additional laboratory testing would be used to determine specific antibody presence.Although there is no potential for serious injury in this case, an mdr will be reported to the fda as a requirement of the emergency use authorization (eua).
 
Event Description
The customer observed a reactive (positive) advia centaur xp sars-cov-2 total (cov2t) result for 1 patient which was considered discordant to two other nonreactive (negative) replicates.The customer did not report the reactive (positive) result.There are no reports of patient intervention or adverse health consequences due to the discordant cov2t result.
 
Manufacturer Narrative
Mdr 1219913-2020-00639 was filed on december 16, 2020.Additional information january 21, 2021: a full review of the system has been performed.No major issues were identified.A review of the customer's data indicates a 1.07% frequency of discordant results.Internally, a frequency of 1.22% discordant results was obtained with lot 003.Siemens continues to investigate the report.
 
Manufacturer Narrative
Mdr 1219913-2020-00639 was filed on december 16, 2020 and mdr 1219913-2020-00639 supplemental 1 was filed on february 11, 2021.Additional information february 11, 2021: the account observed non-reproducible reactive results with advia centaur xp sars-cov-2 total lot 709003.Siemens performed hardware troubleshooting and also performed preventative maintenance.No major issues were found.Cov2t lot 709003 was included in testing performed as part of the investigation for atellica im and advia centaur sars-cov-2 total (cov2t) non-reproducible false reactive results with lots 709004, 709005, 709006, 709035.Cov2t lot 709003 variability and discordant frequency is 1.22% compared to 3.37% for cov2t lots 709005/709035.The rate of incidence at the account is approximately 1.07%.Based on the information provided, no product non-conformance was identified.Cov2t lot 709003 is meeting assay claims.Customer is operational.No further action is needed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR SARS-COV-2 TOTAL (COV2T)
Type of Device
SARS-COV-2 IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS, INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
5086604381
MDR Report Key11023177
MDR Text Key247459152
Report Number1219913-2020-00639
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
EUA201370
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 02/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/12/2021
Device Model NumberN/A
Device Catalogue Number11206710
Device Lot Number003
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/11/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-